Results 1 to 8 of about 8 (8)

Phase I/II study of adding intraperitoneal paclitaxel in patients with pancreatic cancer and peritoneal metastasis

open access: yesBJS (British Journal of Surgery), Volume 107, Issue 13, Page 1811-1817, December 2020., 2020
This multicentre phase I/II study was undertaken to determine the recommended dose of the combination of intravenous gemcitabine, intravenous nab‐paclitaxel and intraperitoneal paclitaxel in patients with pancreatic ductal adenocarcinoma and peritoneal metastasis, and to evaluate its clinical efficacy and safety.
S. Yamada   +18 more
wiley   +1 more source

Adjuvant therapy following oesophagectomy for adenocarcinoma in patients with a positive resection margin

open access: yesBJS (British Journal of Surgery), Volume 107, Issue 13, Page 1801-1810, December 2020., 2020
In UK practice, surgical resection margin status is often used to stratify patients for receipt of adjuvant treatment. This cohort study suggested both an overall and recurrence‐free survival benefit following adjuvant therapy in patients with positive margins, who had undergone neoadjuvant chemotherapy and resectional surgery for oesophageal ...
R. K. Bott   +40 more
wiley   +1 more source

Comparison of the Peritoneal Cancer Index and Dutch region count as tools to stage patients with peritoneal metastases of colorectal cancer

open access: yesBJS Open, Volume 4, Issue 6, Page 1153-1161, December 2020., 2020
This retrospective study compared two classification tools, the Dutch region count and the Peritoneal Cancer Index, for colorectal peritoneal metastases, and validated the results in a separate cohort. The region count was easier to apply, and may benefit doctors who refer patients to expert centres.
F. S. Verheij   +7 more
wiley   +1 more source

Tumour growth rate of carcinoma of the colon and rectum: retrospective cohort study

open access: yesBJS Open, Volume 4, Issue 6, Page 1200-1207, December 2020., 2020
Few studies have evaluated the growth pattern of colorectal cancer. Forty‐three patients who underwent CT twice more than 5 weeks apart were included over a 2‐year interval. The median doubling time was 211 days, with a concerning suggestion of tumour progression.
J. R. Burke   +5 more
wiley   +1 more source

Update of the list of qualified presumption of safety (QPS) recommended microbiological agents intentionally added to food or feed as notified to EFSA 23: Suitability of taxonomic units notified to EFSA until September 2025

open access: yesEFSA Journal, Volume 24, Issue 1, January 2026.
Abstract The qualified presumption of safety (QPS) process was developed to provide a harmonised safety assessment approach to support EFSA Scientific Panels and Units. The QPS approach assesses the taxonomic identity, body of relevant knowledge and safety of microorganisms intentionally added to the food and feed chain.
EFSA Panel on Biological Hazards (BIOHAZ)   +28 more
wiley   +1 more source

Update of the list of qualified presumption of safety (QPS) recommended microbiological agents intentionally added to food or feed as notified to EFSA 22: Suitability of taxonomic units notified to EFSA until March 2025

open access: yesEFSA Journal, Volume 23, Issue 7, July 2025.
Abstract The qualified presumption of safety (QPS) process was developed to assess the safety of microorganisms used in food and feed chains. During the period covered by this Statement, no new information warranted changes to the status of previously recommended QPS taxonomic units.
EFSA Panel on Biological Hazards (BIOHAZ)   +28 more
wiley   +1 more source

Thymopoietin‐α, ‐β, and ‐γ Isoforms Increased Expression in Cervical Cancer Cells

open access: yesCanadian Journal of Infectious Diseases and Medical Microbiology, Volume 2025, Issue 1, 2025.
Cervical cancer (CC) is a public health concern related to the human papillomavirus (HPV) persistent infection. Minichromosome maintenance 2 (MCM2) has been postulated as a surrogate marker for HPV infection. Thymopoietin (TMPO) is a nuclear protein regulated by E2F such as MCM2 or p16. TMPO can give rise to six different isoforms.
Víctor Huerta-Padilla   +15 more
wiley   +1 more source

Publication Only

open access: yes
HemaSphere, Volume 9, Issue S1, June 2025.
wiley   +1 more source
Home - About - Disclaimer - Privacy